HOME >> BIOLOGY >> NEWS
Jefferson scientists propose mechanism to control the body's red blood cell and platelet production

The new work may provide essential background for new therapeutic strategies in red blood cell and platelet disorders

Researchers at Jefferson Medical College have uncovered a potential switch that helps control the manufacture of red blood cells and blood-clotting platelets. By better understanding how the body keeps tight reins on this process, the scientists hope to someday therapeutically control blood cell production.

For our tissues to have the oxygen they crave, we need to have enough circulating red blood cells. Athletes, for example, may artificially increase the number of blood cells using a hormone, erythropoietin, which helps immature red blood cells mature. But at the same time, too many cells can cause sluggish circulation and stroke.

Controlling the amount of the hormone is one way of regulating red blood cell production. But there's another way, called "negative regulation," which involves blocking the growth and differentiation of red cell precursors. By activating the cell's own programmed suicide process, called apoptosis, researchers can halt the excessive production of red blood cells.

Cesare Peschle, M.D., professor of microbiology and immunology at Thomas Jefferson University in Philadelphia, Ruggero De Maria, M.D., and their co-workers at Jefferson's Kimmel Cancer Center and the Istituto Superiore di Sanita in Rome, found evidence that by activating so-called "death receptors" on the surface of immature red blood cells, an important protein called GATA-1 can be turned off. GATA-1 is crucial to the development of immature blood cells.

They report their work September 30 in the journal Nature. A News and Views article accompanies the research publication.

The scientists found that turning on immature red blood cell death receptors triggers caspases, a family of 14 cysteine enzymes that degrade critical cellular proteins, such as GATA-1. This culminates in
'"/>

Contact: Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-6300
Thomas Jefferson University
1-Oct-1999


Page: 1 2

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
4. Jefferson scientists use gene therapy to restore function of damaged heart cells in lab
5. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
6. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
7. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
8. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
9. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
10. Jefferson scientists use gene repair technique to change albino mice hairs to black
11. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/3/2020)... LAGUNA HILLS, Calif. (PRWEB) , ... March 03, 2020 , ... ... 300 spinal levels with the dualX Expanding Interbody Fusion System. , The ... in Fresno, CA. After the case Dr. Najafi noted, “dualX has completely changed ...
(Date:3/2/2020)... ... ... Nominations are now being accepted for the 2020 Women in Biometrics ... and SecureIDNews and co-presented with sponsors IDEMIA , Biometric Update ... year’s Women in Biometrics Awards will be honored at the 2020 SIA GovSummit, held ...
(Date:2/28/2020)... Fla. (PRWEB) , ... February 27, 2020 , ... ... to broadcast 2Q/2020, will explore innovative treatment solutions for maladies, such as Inflammatory ... more info. , This segment will focus on a novel platform developed ...
Breaking Biology News(10 mins):
(Date:3/10/2020)... ... March 10, 2020 , ... Lifecycle Biotechnologies announced today ... Cleburne, Texas to be used as a biopharmaceutical and biotechnology production and development campus. ... offices as well as its production and development hub. The company expects to relocate ...
(Date:3/2/2020)... ... ... McBee, Moore and Vanik IP, LLC (MMV IP) has been ranked 12th ... , According to statistics compiled by Harrity Anaytics, MMV IP was listed as the ... during 2019. Technology center 1600 at the US Patent Office (“USPTO”) specializes in the ...
(Date:2/21/2020)... PURCHASE, N.Y. (PRWEB) , ... February 20, 2020 ... ... solution for ensuring supply chain transparency and reassuring consumers that what’s listed on ... patented and trademarked ingredients, Nutrition21 has introduced this solution with the adoption of ...
(Date:2/19/2020)... , ... February 19, 2020 , ... ... solutions for the life sciences industry, today announced the opening of a new ... Associate Partner, Red Nucleus R&D. , Red Nucleus announced the new office in ...
Breaking Biology Technology:
Cached News: